Ptc Therapeutics, Inc. financial data

Symbol
PTCT on Nasdaq
Industry
Pharmaceutical Preparations
Location
500 Warren Corporate Center Drive, Warren, New Jersey
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
Q1 2024 - Apr 25, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 164 % +19.4%
Quick Ratio 5.98 % +40.3%
Debt-to-equity -312 % +52.1%
Return On Assets -36.9 % -8.03%
Operating Margin -39.6 % +36.2%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 76.7 M shares +3.38%
Common Stock, Shares, Outstanding 76.7 M shares +3.57%
Entity Public Float 2.33 B USD +9.44%
Common Stock, Value, Issued 76 K USD +4.11%
Weighted Average Number of Shares Outstanding, Basic 76.5 M shares +3.75%
Weighted Average Number of Shares Outstanding, Diluted 76.5 M shares +3.75%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 928 M USD +20.4%
Research and Development Expense 588 M USD -16.8%
Operating Income (Loss) -367 M USD +23.2%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -646 M USD -7.53%
Income Tax Expense (Benefit) -66.6 M USD -127%
Net Income (Loss) Attributable to Parent -579 M USD -1.4%
Earnings Per Share, Basic -7.69 USD/shares +2.54%
Earnings Per Share, Diluted -7.69 USD/shares +2.54%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 548 M USD +227%
Marketable Securities, Current 336 M USD +183%
Inventory, Net 30.1 M USD +12.8%
Assets, Current 1.17 B USD +90.5%
Property, Plant and Equipment, Net 92.8 M USD +16.7%
Operating Lease, Right-of-Use Asset 91.2 M USD -8.38%
Intangible Assets, Net (Excluding Goodwill) 330 M USD -51.9%
Goodwill 82.3 M USD 0%
Assets 1.79 B USD +11.2%
Accounts Payable, Current 27.5 M USD +4.36%
Employee-related Liabilities, Current 35.1 M USD -3.73%
Contract with Customer, Liability, Current 801 K USD -40.7%
Liabilities, Current 575 M USD +30.1%
Deferred Income Tax Liabilities, Net 55.9 M USD -45.6%
Operating Lease, Liability, Noncurrent 105 M USD +4.38%
Other Liabilities, Noncurrent 141 K USD 0%
Liabilities 2.68 B USD +29.9%
Accumulated Other Comprehensive Income (Loss), Net of Tax -5.56 M USD -250%
Retained Earnings (Accumulated Deficit) -3.38 B USD -20.7%
Stockholders' Equity Attributable to Parent -894 M USD -95.4%
Liabilities and Equity 1.79 B USD +11.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 70.8 M USD
Net Cash Provided by (Used in) Financing Activities 540 K USD -86.8%
Net Cash Provided by (Used in) Investing Activities -115 M USD -297%
Common Stock, Shares Authorized 250 M shares 0%
Common Stock, Shares, Issued 76.7 M shares +3.57%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -45.7 M USD +26.7%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 565 M USD +142%
Interest Paid, Excluding Capitalized Interest, Operating Activities 3.67 M USD -71.7%
Deferred Tax Assets, Valuation Allowance 834 M USD +24%
Deferred Tax Assets, Gross 841 M USD +24.3%
Operating Lease, Liability 119 M USD +8.51%
Payments to Acquire Property, Plant, and Equipment 9.59 M USD -6.64%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -583 M USD -5.23%
Lessee, Operating Lease, Liability, to be Paid 251 M USD -5.1%
Property, Plant and Equipment, Gross 138 M USD +25.8%
Operating Lease, Liability, Current 14.6 M USD +51.8%
Lessee, Operating Lease, Liability, to be Paid, Year Two 20.5 M USD +0.51%
Lessee, Operating Lease, Liability, to be Paid, Year One 21 M USD +13.7%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Deferred Income Tax Expense (Benefit) -1 K USD +75%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 131 M USD -14.8%
Lessee, Operating Lease, Liability, to be Paid, Year Three 18.4 M USD -7.94%
Unrecognized Tax Benefits 1.36 M USD -95%
Lessee, Operating Lease, Liability, to be Paid, Year Four 17.9 M USD -10.2%
Operating Lease, Payments 3.95 M USD +3.6%
Additional Paid in Capital 2.49 B USD +6.28%
Amortization of Intangible Assets 235 M USD +77.2%
Depreciation, Depletion and Amortization 55.4 M USD +29.4%
Deferred Tax Assets, Net of Valuation Allowance 7.48 M USD +66.8%
Share-based Payment Arrangement, Expense 91.2 M USD -19%